Analyst downgrades: PG, HGSI and MT
Posted Apr 17th 2008 11:07AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Procter and Gamble (PG), Zoltek Co (ZOLT)
.gif)
MOST NOTEWORTHY: Procter & Gamble, Human Genome and Arcelor Mittal were today's noteworthy downgrades:
- Deutsche Bank downgraded shares of Procter & Gamble (NYSE:PG) to Hold from Buy on valuation and their expectation for slowing short-term industry growth, especially in beauty.
- Citigroup downgraded Human Genome (NASDAQ:HGSI) to Hold from Buy as they believe giving up Syncria's royalties removes an important value driver for the stock.
- HSBC downgraded shares of Arcelor Mittal (NYSE:MT) to Neutral from Overweight on valuation and believes the company needs to raise prices more than costs have risen for iron ore, coking coal and steel scrap.
OTHER DOWNGRADES:
Tags: analyst, arcelor mittal, ArcelorMittal, bae systems, baesy, BaeSystems, downgrade, hgsi, human genome, HumanGenome, illinois tool works, IllinoisToolWorks, inthenews, itw, mt, pg, procter gamble, ProcterGamble, zolt, zoltek
Tax Reform in This Election Year: It's Not Likely
Which Credit Card Rewards Does the IRS Care About?
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
